Skip to content
Screener

MeiraGTx Holdings plc MGTX Operating Cash Flow

Operating Cash Flow at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$813M-29.0%
Opus Genetics logo
Opus GeneticsIRD
-$12.73M-41.5%
Regenxbio logo
RegenxbioRGNX
-$62.24M-26.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$54.11M+2.1%
Prime Medicine logo
Prime MedicinePRME
-$41.05M+0.9%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-$68.13M-42.6%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.18B+85.4%
Enterprise value$1.18B+71.1%
P/S14.9×-2.0×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060739
Line itemFor the Three-Month Periods Ended March 31, 2026For the Three-Month Periods Ended March 31, 2025
Lease liabilities(1,266)(4,228)
Other current liabilities55,603(19)
Deferred revenue - related party(50)(329)
Net cash provided by (used in) operating activities17,810(36,828)
Cash flows from investing activities:
Purchase of property, plant and equipment(2,008)(1,710)
Acquisition of in-process research and development assets(250)
Net cash used in investing activities(2,258)(1,710)

Item 1. Financial Statements (Unaudited)

FAQ

What is MeiraGTx Holdings plc's operating cash flow?
MeiraGTx Holdings plc (MGTX) reported operating cash flow of $17.81M in Q1 2026.
How has MeiraGTx Holdings plc's operating cash flow changed year-over-year?
MeiraGTx Holdings plc's operating cash flow increased by 148.4% year-over-year, from -$36.83M to $17.81M.
What is the long-term trend for MeiraGTx Holdings plc's operating cash flow?
Over 2 years (2022 to 2024), MeiraGTx Holdings plc's operating cash flow has grown at a 19.6% compound annual growth rate (CAGR), from -$73.1M to -$104.5M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about MeiraGTx Holdings plc's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude